Status:
COMPLETED
Potential Improvements in the Pre-emergency Department Care for Cancer Patients
Lead Sponsor:
Erasmus Medical Center
Conditions:
Cancer
Emergencies
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this single center prospective cross-sectional study is to identify the facilitators and barriers in the course of the disease that starts when symptoms first arise until patients with sol...
Detailed Description
The goal of this single center prospective cross-sectional study is to identify the facilitators and barriers in the course of the disease that starts when symptoms first arise until patients with sol...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months.
- Presented at or admitted from the emergency department for the oncology, hematology, neuro- or lung-oncology clinical unit.
- Awake and conscious.
- Possible to answer questions within 48 hours after presentation at the emergency department (ED).
- Exclusion Criteria:
- \<18 years old
- Only received a surgical intervention as cancer treatment
- Admitted to the ED for the surgical department
- Not willing or able to give written informed consent
Exclusion
Key Trial Info
Start Date :
January 29 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05974787
Start Date
January 29 2024
End Date
September 1 2024
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015GD